vs

Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and RLI CORP (RLI). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $465.7M, roughly 1.1× RLI CORP). RLI CORP runs the higher net margin — 19.6% vs 6.8%, a 12.8% gap on every dollar of revenue. On growth, RLI CORP posted the faster year-over-year revenue change (6.1% vs -1.7%). Over the past eight quarters, RLI CORP's revenue compounded faster (2.3% CAGR vs -0.1%).

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

RLI Corp. is an American insurance company specializing in property insurance and casualty insurance. It is headquartered in Peoria, Illinois.

MD vs RLI — Head-to-Head

Bigger by revenue
MD
MD
1.1× larger
MD
$493.8M
$465.7M
RLI
Growing faster (revenue YoY)
RLI
RLI
+7.8% gap
RLI
6.1%
-1.7%
MD
Higher net margin
RLI
RLI
12.8% more per $
RLI
19.6%
6.8%
MD
Faster 2-yr revenue CAGR
RLI
RLI
Annualised
RLI
2.3%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MD
MD
RLI
RLI
Revenue
$493.8M
$465.7M
Net Profit
$33.7M
$91.2M
Gross Margin
Operating Margin
9.9%
24.4%
Net Margin
6.8%
19.6%
Revenue YoY
-1.7%
6.1%
Net Profit YoY
10.5%
123.1%
EPS (diluted)
$0.40
$1.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MD
MD
RLI
RLI
Q4 25
$493.8M
$465.7M
Q3 25
$492.9M
$509.3M
Q2 25
$468.8M
$499.8M
Q1 25
$458.4M
$407.7M
Q4 24
$502.4M
$439.1M
Q3 24
$511.2M
$470.0M
Q2 24
$504.3M
$416.4M
Q1 24
$495.1M
$444.8M
Net Profit
MD
MD
RLI
RLI
Q4 25
$33.7M
$91.2M
Q3 25
$71.7M
$124.6M
Q2 25
$39.3M
$124.3M
Q1 25
$20.7M
$63.2M
Q4 24
$30.5M
$40.9M
Q3 24
$19.4M
$95.0M
Q2 24
$-153.0M
$82.0M
Q1 24
$4.0M
$127.9M
Operating Margin
MD
MD
RLI
RLI
Q4 25
9.9%
24.4%
Q3 25
13.8%
30.9%
Q2 25
12.8%
31.3%
Q1 25
7.0%
19.3%
Q4 24
7.8%
10.8%
Q3 24
6.6%
24.9%
Q2 24
-31.3%
24.8%
Q1 24
3.2%
36.0%
Net Margin
MD
MD
RLI
RLI
Q4 25
6.8%
19.6%
Q3 25
14.5%
24.5%
Q2 25
8.4%
24.9%
Q1 25
4.5%
15.5%
Q4 24
6.1%
9.3%
Q3 24
3.8%
20.2%
Q2 24
-30.3%
19.7%
Q1 24
0.8%
28.8%
EPS (diluted)
MD
MD
RLI
RLI
Q4 25
$0.40
$1.00
Q3 25
$0.84
$1.35
Q2 25
$0.46
$1.34
Q1 25
$0.24
$0.68
Q4 24
$0.37
$-2.87
Q3 24
$0.23
$2.06
Q2 24
$-1.84
$1.78
Q1 24
$0.05
$2.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MD
MD
RLI
RLI
Cash + ST InvestmentsLiquidity on hand
$375.2M
Total DebtLower is stronger
$570.5M
Stockholders' EquityBook value
$865.9M
$1.8B
Total Assets
$2.2B
$6.2B
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MD
MD
RLI
RLI
Q4 25
$375.2M
Q3 25
$340.1M
Q2 25
$224.7M
Q1 25
$99.0M
Q4 24
$229.9M
Q3 24
$103.8M
Q2 24
$19.4M
Q1 24
$8.0M
Total Debt
MD
MD
RLI
RLI
Q4 25
$570.5M
Q3 25
$577.2M
$100.0M
Q2 25
$583.9M
$100.0M
Q1 25
$590.5M
$100.0M
Q4 24
$597.1M
$100.0M
Q3 24
$100.0M
Q2 24
$100.0M
Q1 24
$100.0M
Stockholders' Equity
MD
MD
RLI
RLI
Q4 25
$865.9M
$1.8B
Q3 25
$890.7M
$1.9B
Q2 25
$833.8M
$1.7B
Q1 25
$789.2M
$1.6B
Q4 24
$764.9M
$1.5B
Q3 24
$732.5M
$1.7B
Q2 24
$706.5M
$1.6B
Q1 24
$856.2M
$1.5B
Total Assets
MD
MD
RLI
RLI
Q4 25
$2.2B
$6.2B
Q3 25
$2.2B
$6.2B
Q2 25
$2.1B
$6.0B
Q1 25
$2.0B
$5.7B
Q4 24
$2.2B
$5.6B
Q3 24
$2.1B
$5.8B
Q2 24
$2.0B
$5.5B
Q1 24
$2.2B
$5.3B
Debt / Equity
MD
MD
RLI
RLI
Q4 25
0.66×
Q3 25
0.65×
0.05×
Q2 25
0.70×
0.06×
Q1 25
0.75×
0.06×
Q4 24
0.78×
0.07×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MD
MD
RLI
RLI
Operating Cash FlowLast quarter
$114.1M
$156.8M
Free Cash FlowOCF − Capex
$155.0M
FCF MarginFCF / Revenue
33.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
3.39×
1.72×
TTM Free Cash FlowTrailing 4 quarters
$608.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MD
MD
RLI
RLI
Q4 25
$114.1M
$156.8M
Q3 25
$137.3M
$179.2M
Q2 25
$137.2M
$174.7M
Q1 25
$-117.5M
$103.5M
Q4 24
$133.0M
$128.1M
Q3 24
$91.8M
$219.4M
Q2 24
$107.0M
$141.8M
Q1 24
$-125.2M
$70.9M
Free Cash Flow
MD
MD
RLI
RLI
Q4 25
$155.0M
Q3 25
$177.8M
Q2 25
$173.4M
Q1 25
$102.5M
Q4 24
$127.6M
Q3 24
$219.0M
Q2 24
$139.1M
Q1 24
$69.9M
FCF Margin
MD
MD
RLI
RLI
Q4 25
33.3%
Q3 25
34.9%
Q2 25
34.7%
Q1 25
25.1%
Q4 24
29.0%
Q3 24
46.6%
Q2 24
33.4%
Q1 24
15.7%
Capex Intensity
MD
MD
RLI
RLI
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.3%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.7%
Q1 24
0.2%
Cash Conversion
MD
MD
RLI
RLI
Q4 25
3.39×
1.72×
Q3 25
1.91×
1.44×
Q2 25
3.49×
1.41×
Q1 25
-5.66×
1.64×
Q4 24
4.36×
3.13×
Q3 24
4.72×
2.31×
Q2 24
1.73×
Q1 24
-31.03×
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

RLI
RLI

Casualty Segment$246.8M53%
Property Insurance Segment$122.5M26%
Other$59.3M13%
Surety Insurance Segment$37.1M8%

Related Comparisons